CCB Investor Investigation: Coastal Financial Under Investigation for Securities Fraud on behalf of Investors with LossesSeptember 28, 2026
Share Twitter Facebook LinkedIn Email Samsung Bioepis Co., Ltd. has launched OPUVIZ 40 mg/mL solution for injection in a vial, a biosimilar referencing Eylea, across Europe.Read More
